APA (7th ed.) Citation

D, D., K, N., R, P., N, M., VH, G. C., LM, E., & P, I. (2025). Risks and Benefits of Pharmacological Treatment for Pediatric Chronic Non-cancer Pain: When Safety Evidence Lags Behind Prescription Pads. Paediatric drugs, 27(4), 405. https://doi.org/10.1007/s40272-025-00698-2

Chicago Style (17th ed.) Citation

D, Dundaru-Bandi, Niburski K, Pitt R, Mohamed N, Gonzalez Cardenas VH, Einhorn LM, and Ingelmo P. "Risks and Benefits of Pharmacological Treatment for Pediatric Chronic Non-cancer Pain: When Safety Evidence Lags Behind Prescription Pads." Paediatric Drugs 27, no. 4 (2025): 405. https://doi.org/10.1007/s40272-025-00698-2.

MLA (9th ed.) Citation

D, Dundaru-Bandi, et al. "Risks and Benefits of Pharmacological Treatment for Pediatric Chronic Non-cancer Pain: When Safety Evidence Lags Behind Prescription Pads." Paediatric Drugs, vol. 27, no. 4, 2025, p. 405, https://doi.org/10.1007/s40272-025-00698-2.